| Tochukwu Jude Onyekwelu, MD | |
|
9313 Medical Plaza Dr Ste 204, Charleston, SC 29406-9176 | |
| (843) 797-5151 | |
| (843) 572-6939 |
| Full Name | Tochukwu Jude Onyekwelu |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 9313 Medical Plaza Dr Ste 204, Charleston, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376960849 | NPI | - | NPPES |
| BP10064880 | Other | TX | TEXAS MEDICAL BOARD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | BP10064880 (Texas) | Secondary |
| 208600000X | Surgery | 90774 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tochukwu Jude Onyekwelu, MD 9313 Medical Plaza Dr Ste 204, Charleston, SC 29406-9176 Ph: (843) 797-5151 | Tochukwu Jude Onyekwelu, MD 9313 Medical Plaza Dr Ste 204, Charleston, SC 29406-9176 Ph: (843) 797-5151 |
News Archive
Helsinn Group and Pharmacosmos A/S today jointly announce that they have entered into an agreement for the exclusive US commercialization rights to Monofer, an innovative intravenous iron replacement therapy under development for the treatment of Iron Deficiency Anemia.
A new scoping review found that those with chronic health concerns, such as diabetes, heart disease, cancer, and autoimmune conditions, are not only at a higher risk of severe COVID-19 infection, they are also more likely to experience anxiety, depression or substance use during the COVID-19 pandemic.
Liverpool City Council is seriuously considering a ban on the word "obese" because it is offensive to overweight and fat children. They plan to replace it with 'unhealthy weight'. Many parents and health authorities cosider this too much and condemn it as 'preposterous'. This idea originated at a mock parliament held in a Liverpool school manned by around 90 students.
Oregon Health & Science University Doernbecher Children's Hospital will lead the next phase of a landmark clinical trial to further assess the safety and preliminary effectiveness of purified human neural stem cells (HuCNS-SC-) as a potential treatment for infantile or late-infantile neuronal ceroid lipofuscinosis (NCL), a rare and currently fatal neurodegenerative disorder that affects infants and children.
› Verified 4 days ago
Dr. Michael Charles O'laughlin, MD Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 843-792-3072 | |
Kyler Perry, DO Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2300 | |
Dr. Swathi Venattu, MD Surgery Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Antwana Sharee Wright, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Jacob Arthur Klapper, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Norman Robert Harvey, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-2123 | |
Hyejin Kwon, MD Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave, Charleston, SC 29425 Phone: 843-792-3072 |